TrueBlue (TBI) Tops Q2 EPS by 28c
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $8.06 -0.74%
EPS Growth %: +142.9%
Financial Fact:
Interest and other income, net: -867K
Today's EPS Names:
CCEL, SLP, TMQ, More
EPS Growth %: +142.9%
Financial Fact:
Interest and other income, net: -867K
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
TrueBlue (NYSE: TBI) reported Q2 EPS of $0.82, $0.28 better than the analyst estimate of $0.54. Revenue for the quarter came in at $569 million versus the consensus estimate of $572.77 million.
For earnings history and earnings-related data on TrueBlue (TBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Kepler Cheuvreux Upgrades Epiroc AB (EPIA:SS) (EPOKY) to Buy
- ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
